ECDC and the WHO Regional Office for Europe (WHO/Europe) recently concluded a crucial joint meeting focused on enhancing tuberculosis (TB) surveillance and monitoring across the WHO European Region.
In a concerted effort to combat healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), the European Centre for Disease Prevention and Control (ECDC) and the Belgian EU Presidency on 6-7 May co-hosted a conference at the national public health institute of Belgium, Sciensano, in Brussels.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
Archive of the monthly measles and rubella reports which started being published on 22 April 2024, including retroactive issues from January 2024. New reports are added on a weekly basis.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.